Cti Biopharma Corp buy melinda
Start price
20.01.12
/
50%
€45.75
Target price
20.07.12
€92.50
Performance (%)
-49.62%
End price
20.07.12
€23.05
Summary
This prediction ended on 20.07.12 with a price of €23.05. Massive losses of -49.62% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cti Biopharma Corp | - | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% | 69.888% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% | 101.814% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% | 45.300% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% | 63.763% |
Comments by melinda for this prediction
In the thread Cti Biopharma Corp diskutieren
Krebsbehandlung
Cell Therapeutics Inc. sieht vor, dass die Europäische Arzneimittel-Agentur kann eine Stellungnahme über die Zulassung von demnde pixuvry Mitte Februar-Ausgabe
(Laufzeit überschritten)
Stopped prediction by melinda for Cti Biopharma Corp
Cti Biopharma Corp
Start price
Target price
Perf. (%)
€2.00
31.07.18
31.07.18
€2.71
30.10.19
30.10.19
-64.89%
30.10.19
30.10.19
Cti Biopharma Corp
Start price
Target price
Perf. (%)
€10.03
22.05.13
22.05.13
€12.00
22.11.13
22.11.13
52.14%
22.11.13
22.11.13
Cti Biopharma Corp
Start price
Target price
Perf. (%)
€29.17
12.09.12
12.09.12
€40.00
12.03.13
12.03.13
-66.68%
12.03.13
12.03.13